$86.50
-1.51-1.72%
Last update: Oct 26, 9:25 AM
Abivax SA (ABVX) Stock Price, Quote, News & History
ABVXNASDAQ
Abivax (ABVX) stock skyrockets 36% following strong Phase 3 maintenance data for its ulcerative colitis treatment. Get the latest details.
You can purchase shares of Abivax (NASDAQ:ABVX) through any online brokerage.
Other companies in Abivax’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Abivax has a consensus price target of $119.86.
The stock price for Abivax (NASDAQ: ABVX) is $88.28 last updated October 26, 2026 at 9:25 AM EDT.
There are no upcoming dividends for Abivax.
Abivax does not have any upcoming earnings scheduled.
There is no upcoming split for Abivax.
Abivax is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is...
